Febuxostat Reduces Contrast-Induced Acute Kidney Injury in Stage 3 CKD
Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.
Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.
Higher risk following elective endovascular abdominal aortic aneurysm repair seen for patients with decreased renal function, women, and aneurysm >6.9 cm
Given the widespread use of contrast medium in cardiovascular and other imaging, continued focus on preventing contrast-induced acute kidney injury is warranted.
Transient hypotension increases the risk for post-contrast acute kidney injury following computed tomography with contrast media, according to investigators.
Reduced incidence of AKI seen in association with multifaceted intervention, including clinical decision support, audit, feedback
Latest findings from a study of RenalGuard contrast with those of previous randomized controlled trials.
Previous research suggested that allopurinol, a xanthine oxidase inhibitor, prevents the formation of oxygen-free radicals that may contribute to contrast nephropathy.
BNP or NT-proBNP may represent effective markers for the prediction of contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing coronary angiography.
Gadavist® Imaging Bulk Package is supplied as 604.72mg/mL of gadobutrol in 30mL and 65mL multidose containers.
Radiologists and clinicians should weigh the relative benefits and risks of using IV contrast in patients with eGFRs less than 30 mL/min/1.73 m2, according to a consensus statement.